Vascular Growth Factors and Receptors in Capillary Hemangioblastomas and Hemangiopericytomas

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 1996 Mar 1

PMID 8774132

Citations 30

Authors

E Hatva

T Bohling

J Jaaskelainen

M G Persico

M Haltia

K Alitalo

Affiliations

Soon will be listed here.

Abstract

Capillary hemangioblastomas and hemangiopericytomas are highly vascular central nervous system tumors of controversial origin. Of interest in their pathogenesis are mechanisms regulating endothelial cell growth. The endothelial cell mitogen vascular endothelial growth factor (VEGF) stimulates angiogenesis, and together with its two receptor tyrosine kinases VEGFR-1(FLT1) and VEGFR-2(KDR), is up-regulated during the malignant progression of gliomas. We have analyzed the expression of VEGF and its receptors, the related placental growth factor (PlGF) and the endothelial receptors FLT4 and Tie by in situ hybridization in capillary hemangioblastomas and hemangiopericytomas. VEGF mRNA was up-regulated in all of the hemangiopericytomas studied and highly expressed in the stromal cells of hemangioblastomas. In addition, some hemangioblastoma tumor cells expressed high levels of PlGF. Significantly elevated levels of Tie mRNA, Tie protein, VEGFR-1, and VEGFR-2 but not FLT4 mRNAs were observed in the endothelia of both tumor types. In hemangioblastomas, however, the receptors were also highly expressed by a subpopulation of stromal cells. Consistent results were obtained for a human hemangioblastoma cell line in culture. Up-regulation of the endothelial growth factors and receptors may result in autocrine or paracrine stimulation of endothelial cells and their precursors involved in the genesis of these two vascular tumors.

Citing Articles

Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond.

de Bernardi A, Dufresne A, Mishellany F, Blay J, Ray-Coquard I, Brahmi M Cancers (Basel). 2022; 14(4).

PMID: 35205812 PMC: 8870479. DOI: 10.3390/cancers14041064.

Molecular targeted therapy for advanced or metastatic soft tissue sarcoma.

Yuan J, Li X, Yu S Cancer Control. 2021; 28:10732748211038424.

PMID: 34844463 PMC: 8727831. DOI: 10.1177/10732748211038424.

A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons.

Martin-Broto J, Mondaza-Hernandez J, Moura D, Hindi N Cancers (Basel). 2021; 13(12).

PMID: 34200924 PMC: 8230482. DOI: 10.3390/cancers13122913.

Solid vs. cystic predominance in posterior fossa hemangioblastomas: implications for cerebrovascular risks and patient outcome.

Moscovici S, Candanedo C, Spektor S, Cohen J, Kaye A Acta Neurochir (Wien). 2021; 164(5):1357-1364.

PMID: 33811520 DOI: 10.1007/s00701-021-04828-w.

Solitary Fibrous Tumor/Hemangiopericytoma Metastasizes Extracranially, Associated with Altered Expression of WNT5A and MMP9.

Hong J, Noh M, Akanda M, Kim Y, Kim S, Jung T Cancers (Basel). 2021; 13(5).

PMID: 33799999 PMC: 7962064. DOI: 10.3390/cancers13051142.

References

Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico M, Terman B . The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med. 1993; 178(6):2077-88. PMC: 2191284. DOI: 10.1084/jem.178.6.2077. View

Sato H, Seiki M . Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene. 1993; 8(2):395-405. View

Berse B, Brown L, Van de Water L, Dvorak H, Senger D . Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 1992; 3(2):211-20. PMC: 275520. DOI: 10.1091/mbc.3.2.211. View

Takahashi A, Sasaki H, Kim S, Tobisu K, Kakizoe T, Tsukamoto T . Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res. 1994; 54(15):4233-7. View

Soker S, Vlodavsky I, Neufeld G . The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem. 1992; 267(9):6093-8. View

Ferrara N, Henzel W . Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989; 161(2):851-8. DOI: 10.1016/0006-291x(89)92678-8. View

Rupp E, Siegbahn A, Ronnstrand L, Wernstedt C, Claesson-Welsh L, Heldin C . A unique autophosphorylation site in the platelet-derived growth factor alpha receptor from a heterodimeric receptor complex. Eur J Biochem. 1994; 225(1):29-41. DOI: 10.1111/j.1432-1033.1994.00029.x. View

Neumann H, Eggert H, Scheremet R, Schumacher M, Mohadjer M, Wakhloo A . Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry. 1992; 55(10):898-901. PMC: 1015185. DOI: 10.1136/jnnp.55.10.898. View

Horak E, Leek R, Klenk N, Lejeune S, Smith K, Stuart N . Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet. 1992; 340(8828):1120-4. DOI: 10.1016/0140-6736(92)93150-l. View

10.

Nemes Z . Fibrohistiocytic differentiation in capillary hemangioblastoma. Hum Pathol. 1992; 23(7):805-10. DOI: 10.1016/0046-8177(92)90351-3. View

11.

Deck J, Rubinstein L . Glial fibrillary acidic protein in stromal cells of some capillary hemangioblastomas: significance and possible implications of an immunoperoxidase study. Acta Neuropathol. 1981; 54(3):173-81. DOI: 10.1007/BF00687739. View

12.

Maglione D, Guerriero V, Viglietto G, Persico M . Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A. 1991; 88(20):9267-71. PMC: 52695. DOI: 10.1073/pnas.88.20.9267. View

13.

Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M . Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood. 1992; 80(10):2548-55. View

14.

Kamitani H, Masuzawa H, Sato J, Kanazawa I . Capillary hemangioblastoma: histogenesis of stromal cells. Acta Neuropathol. 1987; 73(4):370-8. DOI: 10.1007/BF00688262. View

15.

Soker S, Goldstaub D, Svahn C, Vlodavsky I, Levi B, Neufeld G . Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors. Biochem Biophys Res Commun. 1994; 203(2):1339-47. DOI: 10.1006/bbrc.1994.2329. View

16.

Traweek S, Kandalaft P, Mehta P, Battifora H . The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol. 1991; 96(1):25-31. DOI: 10.1093/ajcp/96.1.25. View

17.

MARTIN P, Papayannopoulou T . HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science. 1982; 216(4551):1233-5. DOI: 10.1126/science.6177045. View

18.

Morii K, Tanaka R, Washiyama K, Kumanishi T, Kuwano R . Expression of vascular endothelial growth factor in capillary hemangioblastoma. Biochem Biophys Res Commun. 1993; 194(2):749-55. DOI: 10.1006/bbrc.1993.1885. View

19.

Maher E, Yates J, Harries R, Benjamin C, Harris R, Moore A . Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990; 77(283):1151-63. DOI: 10.1093/qjmed/77.2.1151. View

20.

Wilkinson D, Bailes J, McMahon A . Expression of the proto-oncogene int-1 is restricted to specific neural cells in the developing mouse embryo. Cell. 1987; 50(1):79-88. DOI: 10.1016/0092-8674(87)90664-7. View